Antecedent infections in CIDP: A relevant clue in a complex disease?

Affiliations

Editorial

H Stephan Goedee. Muscle Nerve. 2021 Dec.

. 2021 Dec;64(6):637-638.

doi: 10.1002/mus.27424. Epub 2021 Oct 12.

¹ Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, UMC Utrecht, Utrecht, The Netherlands.

No abstract available

Comment on

Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study.
Rajabally YA, Peric S, Bozovic I, Loo LK, Kalac A, Palibrk A, Basta I. Rajabally YA, et al. Muscle Nerve. 2021 Dec;64(6):657-661. doi: 10.1002/mus.27374. Epub 2021 Jul 27. Muscle Nerve. 2021. PMID: 34263956

1. Koike H, Nishi R, Ikeda S, et al. Ultrastructural mechanisms of macrophage-induced demyelination in CIDP. Neurology. 2018;91(23):1051-1060.
1. Ikeda S, Koike H, Nishi R, et al. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2019;90(9):988-996.
1. Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015;86(11):1186-1195.
1. Querol L, Devaux J, Rojas-Garcia R, Illa I. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications. Nat Rev Neurol. 2017;13(9):533-547.
1. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988;24(1):73-78.